Biogen grapples with 'reckoning' over controversial Alzheimer's drug, reporters find
WBUR's All Things Considered host Lisa Mullins talks with STAT biotech reporter Damian Garde about the publication's recent special report on problems at Cambridge-based Biogen. |!…
